Stanley Druckenmiller — Portfolio & 13F Holdings

Duquesne Family Office · 2026-Q2 · filed 2026-08-14 · SEC Form 13F-HR

$3.2M
Portfolio Value
67
Positions
35
New Buys
18
Exits

Latest Quarter Activity

Stanley Druckenmiller Portfolio — Top 50 of 67 Holdings (2026-Q2)

#TickerValueWeightSharesΔ Qtr
1 NTRA
Natera Inc
$865K 26.6% 3.2M +4%
2 STM
Stmicroelectronics N V
$232K 7.2% 3.1M +18.8%
3 INSM
Insmed Inc
$152K 4.7% 1.4M +23.4%
4 FOXA
Fox Corp
$145K 4.5% 2.8M NEW
5 YPF
Ypf Sociedad Anonima
$143K 4.4% 3.1M -3%
6 AMZN
Amazon Com Inc
$129K 4.0% 542K +1082.5%
7 TBBB
Bbb Foods Inc
$121K 3.7% 2.9M -6.7%
8 GOOGL
Alphabet Inc
$120K 3.7% 336K NEW
9 SE
Sea Ltd
$105K 3.2% 1.1M —
10 CDW
Cdw Corp
$105K 3.2% 744K NEW
11 SNDK
Sandisk Corp
$79K 2.4% 35K -8.5%
12 RVMD
Revolution Medicines Inc
$75K 2.3% 400K +26.5%
13 BTDR
Bitdeer Technologies Group
$65K 2.0% 4.1M NEW
14 DAL
Delta Air Lines Inc
$56K 1.7% 603K NEW
15 FLR
Fluor Corp
$51K 1.6% 982K NEW
16 CPNG
Coupang Inc
$46K 1.4% 2.7M —
17 AMD
Advanced Micro Devices Inc
$42K 1.3% 73K NEW
18 PANW
Palo Alto Networks Inc
$40K 1.2% 117K NEW
19 CLF
Cleveland-Cliffs Inc New
$40K 1.2% 4.2M +82.2%
20 HUT
Hut 8 Corp
$36K 1.1% 314K NEW
21 CAI
Caris Life Sciences Inc
$34K 1.0% 1.9M —
22 WWD
Woodward Inc
$29K 0.9% 67K -68.2%
23 NUVB
Nuvation Bio Inc
$26K 0.8% 4.5M —
24 PTGX
Protagonist Therapeutics Inc
$26K 0.8% 209K +30.8%
25 ROKU
Roku Inc
$25K 0.8% 184K -75.5%
26 ADMA
Adma Biologics Inc
$23K 0.7% 2.8M +80.1%
27 PURR
Hyperliquid Strategies Inc
$23K 0.7% 2.9M NEW
28 RMBS
Rambus Inc Del
$23K 0.7% 173K NEW
29 RYTM
Rhythm Pharmaceuticals Inc
$23K 0.7% 204K NEW
30 SKY
Champion Homes Inc
$22K 0.7% 254K NEW
31 DAKT
Daktronics Inc
$22K 0.7% 1.1M +99.6%
32 PCT
Purecycle Technologies Inc
$22K 0.7% 2.7M +178.4%
33 SCCO
Southern Copper Corp
$21K 0.7% 123K +1%
34 LIN
Linde Plc
$21K 0.7% 41K —
35 ENTG
Entegris Inc
$21K 0.7% 118K NEW
36 U
Unity Software Inc
$21K 0.7% 739K —
37 AEVA
Aeva Technologies Inc
$21K 0.6% 720K NEW
38 RIOT
Riot Platforms Inc
$21K 0.6% 755K NEW
39 Q
Qnity Electronics Inc
$21K 0.6% 126K —
40 EQIX
Equinix Inc
$19K 0.6% 18K NEW
41 LRCX
Lam Research Corp
$19K 0.6% 44K NEW
42 DFTX
Definium Therapeutics Inc
$17K 0.5% 357K NEW
43 BLTE
Belite Bio Inc Sponsored
$16K 0.5% 106K —
44 TXG
10x Genomics Inc
$15K 0.5% 403K NEW
45 XENE
Xenon Pharmaceuticals Inc
$14K 0.4% 239K —
46 OLMA
Olema Pharmaceuticals Inc
$12K 0.4% 987K —
47 RGEN
Repligen Corp
$11K 0.3% 77K NEW
48 BIDU
Baidu Inc
$10K 0.3% 88K NEW
49 ARM
Arm Holdings Plc
$10K 0.3% 28K -73.7%
50 CVNA
Carvana Co
$10K 0.3% 151K NEW

Source: SEC EDGAR Form 13F-HR. 13F filings disclose long US equity positions with a 45-day reporting lag and exclude shorts, cash, bonds and non-US holdings — they are a partial, delayed snapshot. Educational only, not investment advice.

Disclosed Portfolio Value by Quarter

$2.7M 2025-Q4 $2.2M 2026-Q1 $3.4M 2026-Q2

Sum of disclosed long US equity positions per 13F quarter. History accrues from mid-2026 onward.

Want rules instead of guru-watching?

13F filings arrive 45 days late. Our three systematic strategies publish a verifiable month-by-month track record — Premium members see the exact 25 holdings of each basket at every monthly rebalance. Performance and backtests stay public.

See Premium — $19/mo

Other Famous Investors